Cargando…

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation

Selective protein degradation platforms have afforded new development opportunities for therapeutics and tools for biological inquiry. The first lysosome targeting chimeras (LYTACs) targeted extracellular and membrane proteins for degradation by bridging a target protein to the cation-independent ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Green, Banik, Steven M., Miller, Caitlyn L., Riley, Nicholas M., Cochran, Jennifer R., Bertozzi, Carolyn R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387313/ https://www.ncbi.nlm.nih.gov/pubmed/33767387 http://dx.doi.org/10.1038/s41589-021-00770-1

Ejemplares similares

Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
por: Alabi, Shanique B., et al.
Publicado: (2021)

Degradation from the outside-in: targeting extracellular and membrane proteins for degradation through the endo-lysosomal pathway
por: Ahn, Green, et al.
Publicado: (2021)

IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins
por: Mikitiuk, Michał, et al.
Publicado: (2023)

Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023)

Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023)

Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles
por: Li, Yang, et al.
Publicado: (2021)

Two pathways for the degradation of the H2 subunit of the asialoglycoprotein receptor in the endoplasmic reticulum
Publicado: (1993)

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Intracellular degradation of unassembled asialoglycoprotein receptor subunits: a pre-Golgi, nonlysosomal endoproteolytic cleavage
Publicado: (1989)

Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor
Publicado: (1983)

Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface
Publicado: (1982)

Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells
Publicado: (1982)

Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity
por: Roggenbuck, Dirk, et al.
Publicado: (2012)

Impact of Asialoglycoprotein Receptor and Mannose Receptor Deficiency on Murine Plasma N-glycome Profiles
por: Svecla, M., et al.
Publicado: (2023)

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
por: Trerè, D, et al.
Publicado: (1999)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
por: Nair, Anroop B., et al.
Publicado: (2019)

Specific capture of glycosylated graphene oxide by an asialoglycoprotein receptor: a strategic approach for liver-targeting
por: Diaz-Galvez, Kevin R., et al.
Publicado: (2019)

Nonlysosomal, pre-Golgi degradation of unassembled asialoglycoprotein receptor subunits: a TLCK- and TPCK-sensitive cleavage within the ER
Publicado: (1991)

Receptor-mediated endocytosis of asialoglycoproteins by rat hepatocytes: receptor-positive and receptor-negative endosomes
Publicado: (1986)

Ligand- and weak base-induced redistribution of asialoglycoprotein receptors in hepatoma cells
Publicado: (1987)

Three-Dimensional Models of the Oligomeric Human Asialoglycoprotein Receptor (ASGP-R)
por: Massarelli, Ilaria, et al.
Publicado: (2010)

A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation
por: Christie, Michelle P., et al.
Publicado: (2014)

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

An in vivo Method for Determination of Endosomal Distribution of Both Ligand and Asialoglycoprotein Receptor in Rat Liver
por: Dalton, Shana R, et al.
Publicado: (2004)

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)

A Novel Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting
por: Zhang, Pu, et al.
Publicado: (2016)

Intracellular segregation of asialoglycoproteins and their receptor: a prelysosomal event subsequent to dissociation of the ligand-receptor complex
Publicado: (1984)

Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: biochemical characterization of the endosomal compartments
Publicado: (1985)

Effect of lysosomotropic amines on the secretory pathway and on the recycling of the asialoglycoprotein receptor in human hepatoma cells
Publicado: (1985)

Rat hepatocytes bind to synthetic galactoside surfaces via a patch of asialoglycoprotein receptors
Publicado: (1980)

Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
por: Yousef, Shaimaa, et al.
Publicado: (2018)

Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
por: Schmidt, Karsten, et al.
Publicado: (2017)

Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to LPS/Galactosamine Liver Injury and Protection by Betaine Administration
por: Rasineni, Karuna, et al.
Publicado: (2020)

Triantennary GalNAc-Functionalized Multi-Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor
por: Cordeiro, Rosemeyre, et al.
Publicado: (2022)

The H1 and H2 polypeptides associate to form the asialoglycoprotein receptor in human hepatoma cells
Publicado: (1988)

Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin
por: Susan-Resiga, Delia, et al.
Publicado: (2021)

Relations between the intracellular pathways of the receptors for transferrin, asialoglycoprotein, and mannose 6-phosphate in human hepatoma cells
Publicado: (1989)

Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor
por: Scharner, Juergen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aorilcm7nf2hvub06dhnim8uk8